Hydrocephalus specifies a disorder of cerebrospinal fluid (CSF) physiology resulting in abnormal expansion of the cerebral ventricles, associated with increased intracranial pressure in certain subtypes. An equilibrium between CSF production and CSF reabsorption maintains mean CSF pressure at 5–25 cm of water in normal adults. In patients with communicating and noncommunicating forms of hydrocephalus, the buildup of extra CSF fluid within the ventricles may cause increased intracranial pressure. Idiopathic normal pressure hydrocephalus (iNPH) causing ventriculomegaly without intracranial hypertension is a related and under-reported condition. The epidemiology of hydrocephalus is greatly disputed. Due to etiological heterogeneity, lack of a conclusive definition, and regional treatment variations, the true incidence of hydrocephalus is not known in adults or children. Clinical features, especially in children, commonly include a classical complex of elevated intracranial pressure, headache, vomiting, and drowsiness. Less common clinical features may include papilledema, abducens nerve palsy, and lethargy. iNPH typically presents with some combination of gait, cognitive impairment, and urinary dysfunction. Investigation centers around radiological modalities such as computed tomography and magnetic resonance imaging scans with the addition of CSF sampling to assess mean CSF pressure and CSF drainage. Treatment of hydrocephalus is based on a number of factors, including age, etiology, severity, and supplementary testing. Treatment is usually indicated wherever hydrocephalus is considered to be progressive. Surgical intervention is central to management. This chapter discusses the classification, epidemiology, pathophysiology, diagnosis and treatment, controversies, and future research agendas for hydrocephalus—a condition with an economic burden that outweighs its resources allocation.